ROCKWELL MEDICAL, INC. (RMTI)

↓ Download CSV

CIK 0001041024 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, ROCKWELL MEDICAL, INC. reported revenue of $69.26M, down 31.8% from the prior year. The company ran a net loss, with a net margin of -7.7% and a gross margin of 16.9%. It held $57.15M in total assets against $20.16M in total liabilities.

Key ratios (FY2025)

16.9%
Gross margin
-6.8%
Operating margin
-7.7%
Net margin
-14.4%
Return on equity
-31.8%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$69.26M$101.49M$83.61M$72.81M$61.93M$62.20M$61.30M$63.39M$57.30M
Cost of Revenue$57.56M$84.00M$74.91M$68.73M$64.35M$59.47M$58.46M$64.97M$53.60M
Gross Profit$11.70M$17.48M$8.70M$4.08M-$2.42M$2.73M$2.84M-$1.58M$3.70M$6.75M
Operating Income-$4.69M$608.0K-$6.67M-$16.78M-$30.34M-$28.42M-$34.52M-$32.44M-$25.92M-$20.21M
Net Income-$5.31M-$480.0K-$8.44M-$18.68M-$32.67M-$30.89M-$34.13M-$32.13M-$25.92M-$19.80M
EPS (Diluted)$-0.15$-0.03$-0.37$-1.31$-3.83$-0.41$-0.51$-0.39
Total Assets$57.15M$59.21M$52.17M$46.63M$48.57M$77.75M$44.32M$52.56M$58.78M$83.15M
Total Liabilities$20.16M$26.62M$30.88M$32.53M$46.04M$43.58M$24.00M$25.28M$25.87M
Shareholders' Equity$36.98M$32.59M$21.29M$14.11M$2.54M$34.17M$20.32M$27.28M$32.91M$52.96M
Cash & Equivalents$10.71M$15.66M$8.98M$10.10M$13.28M$48.68M$11.79M$22.71M$8.41M$17.18M
Operating Cash Flow-$659.0K$4.20M-$9.41M-$16.93M-$33.53M-$29.64M-$27.25M-$20.42M-$21.11M-$12.45M
Capital Expenditures$542.0K$1.01M$284.0K
Shares Outstanding39.41M34.06M29.13M12.16M8.54M93.57M65.38M57.03M51.77M51.53M